HOME  | COMPANY| PIPELINE | PARTNERING | NEWS | CAREERS |
Home
Company
Pipeline
Partnering
News
Careers

 

Abeille Pharmaceuticals, Inc., based in Princeton, New Jersey, is a private pharmaceutical product development company incorporated in late 2003. Abeille’s mission is to develop pharmaceutical products with a focus on improving a drug's administration such that it enhances the convenience, improves compliance, and/or ameliorates the side-effects profile for patients.

The company’s initial focus is on developing products in oncology supportive care and diabetes and related metabolic disorders, based on technologies such as transdermal delivery and oral controlled-release systems. At Abeille, we create a strong proprietary position around each of the products we pursue. This is achieved through our internal efforts and is further complimented through the acquisition and/or in-licensing of intellectual property rights related to the pipeline products.

The products being developed by Abeille will seek to fill market niches that each account for several tens of millions of dollars in potential sales. Each product will help address a current unmet need, be it a therapeutic benefit, increased safety, improved convenience and compliance, or reduced cost of therapy for patients.

 

 



Latest News
ABEILLE LICENSES AB-1001 TO PROSTRAKAN FOR NORTH AMERICA, EUROPE AND OTHER TERRITORIES

 

© Abeille Pharmaceuticals, Inc 2004 - 2012
Computer Service
by Blueclone